Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 6078.0 | 62 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 9108.0 | 38 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 12834.0 | 51 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 1015.5 | 44 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 2959.0 | 57 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 101.5 | 48 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 1042.5 | 46 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 269.0 | 64 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 206.0 | 54 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 108.0 | 52 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 1954.0 | 89 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1778.0 | 45 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1799.0 | 52 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 603.0 | 75 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 494.0 | 60 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 126.0 | 44 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 66.5 | 58 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 2360.5 | 40 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1319.0 | 28 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1116.0 | 40 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1161.0 | 23 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 133.0 | 60 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 112.0 | 33 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 125.0 | 52 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 218.0 | 37 |